COVID-19, postcovid syndrome and postvaccination complications at neurology outpatient clinic
Authors:
Karla Hrušová
Authors‘ workplace:
Neurologická ambulance, Ostrava
Published in:
Čas. Lék. čes. 2021; 160: 340-343
Category:
Case Report
Overview
This article describes a collection of patients who visited our neurology outpatient clinic between autumn 2020 and 2021 due to COVID-19, postcovid syndrome or neurological complications in possible relation to vaccination. It is a summary of individual patients’ cases; the author is aware of the statistically insignificant size and characteristics of this collection of patients. Amongst the patients treated for COVID-19, was identified a group of patients with a negative PCR test. In these cases, the diagnosis was determined based on a clinical review, epidemiological anamnesis and antibody testing. In case of continuation or aggravation of the COVID-19 symptoms, it was found beneficial to prescribe 20–60 mg of prednisone at the beginning of the second week of infection. Furthermore, this article describes the most frequent neurological postcovid complications and the effect of short-term pulse treatment by the prescription of 8 mg of methylprednisolone for 15 days. We also report a collection of patients with neurological complications in possible relation to vaccination against COVID-19.
Keywords:
corticosteroid – COVID-19 – postcovid syndrome – postvaccination complications – prednisone – methylprednisolone
Sources
- Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
- Otruba P, Bardoň J, Kolář M a kol. Neurologické komplikace koronavirové infekce SARS-CoV-2 (COVID-19). Neurologie pro praxi 2020; 21 (Suppl. G): 14.
- Vojáček JF. Trombotické komplikace COVID-19. Krátký přehled současných názorů. Intervenční a akutní kardiologie 2021; 20: 98–101.
- Tesař V, Hartinger J. Použití léků vyvinutých pro jiné indikace v léčbě infekce COVID-19. Vnitřní lékařství 2021; 67: 191–192.
- RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021; 384: 693–704.
- Křupka M, Kosztyu P, Račanský M a kol. Možnosti a principy vakcinace proti covidu-19. Praktické lékárenství 2021; 1: 7–13.
- Beran J, Špajdel M, Katzerová V et al. Inosine pranobex significantly decreased the case-fatality rate among PCR positive elderly with SARS-CoV-2 at three nursing homes in the Czech Republic. Pathogens 2020; 9(12): 1055.
- Soukup J. Komunikace s pacienty, kteří váhají s očkováním proti COVID-19: jak může pomoci metoda motivačních rozhovorů. Medicína pro praxi 2021; 18: 211–214.
- ECDC. COVID-19 surveillance guidance – Transition from COVID-19 emergency surveillance to routine surveillance of respiratory pathogens. European Centre for Disease Prevention and Control, 18. 10. 2021. Dostupné na: www.ecdc.europa.eu/en/publications-data/covid-19-surveillance-guidance
- ÚZIS. Zaznamenání kontraindikace očkování proti onemocnění COVID-19 v informačním systému infekčních nemocí ISIN. Ústav zdravotnických informací a statistiky, 14. 1. 2022. Dostupné na: www.uzis.cz/res/file/covid/covid-19-ockovani-kontraindikace-isin-manual.pdf
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
2021 Issue 7–8
Most read in this issue
- COVID-19, postcovid syndrome and postvaccination complications at neurology outpatient clinic
- Manuál k elektronickému zdravotnictví
- Mitochondria – from origin to current therapies
- Telemedicína? Inovace!